Sharmila Banerjee Selected Research

Sharmila Banerjee Research Topics

Disease

41	Neoplasms (Cancer) 09/2023 - 02/2003
18	Pain (Aches) 10/2021 - 08/2002
17	Neoplasm Metastasis (Metastasis) 09/2023 - 08/2002
9	Neuroendocrine Tumors (Neuroendocrine Tumor) 04/2022 - 06/2011
8	Breast Neoplasms (Breast Cancer) 02/2024 - 07/2005
8	Prostatic Neoplasms (Prostate Cancer) 04/2021 - 10/2011
6	Thyroid Neoplasms (Thyroid Cancer) 10/2022 - 05/2015
6	Fibrosarcoma 01/2018 - 02/2010
5	Hypoxia (Hypoxemia) 01/2016 - 07/2005
4	Carcinoma (Carcinomatosis) 10/2021 - 11/2006
3	Lymphoma (Lymphomas) 09/2023 - 02/2010
3	Liver Neoplasms (Liver Cancer) 05/2009 - 07/2008
2	Nausea 02/2024 - 01/2021
2	Infertility (Sterility) 01/2020 - 11/2014
2	Non-Hodgkin Lymphoma (Lymphosarcoma) 12/2019 - 01/2017
2	Osteosarcoma (Osteogenic Sarcoma) 06/2017 - 01/2016
2	Melanoma (Melanoma, Malignant) 03/2017 - 06/2007
2	Hepatocellular Carcinoma (Hepatoma) 01/2016 - 10/2010
1	Ovarian Epithelial Carcinoma 06/2022
1	Abdominal Pain (Pain, Abdominal) 01/2021
1	Medullary Carcinoma 01/2020
1	B-Cell Lymphoma (Lymphoma, B Cell) 12/2019
1	Glioblastoma (Glioblastoma Multiforme) 05/2019
1	Glioma (Gliomas) 05/2019
1	Bone Neoplasms (Bone Cancer) 10/2018
1	Anaplastic Thyroid Carcinoma 09/2018

Drug/Important Bio-Agent (IBA)

21	Radioisotopes (Radionuclides)IBA 04/2022 - 12/2004
17	RadiopharmaceuticalsIBA 10/2021 - 12/2004
10	1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA 04/2024 - 08/2004
8	Somatostatin Receptors (Somatostatin Receptor)IBA 01/2021 - 08/2004
7	Peptide Receptors (Peptide Receptor)IBA 04/2022 - 01/2016
6	AcidsIBA 06/2017 - 12/2004
6	PorphyrinsIBA 02/2015 - 02/2010
5	LigandsIBA 06/2022 - 05/2004
4	lutetium ethylenediaminetetramethylene phosphonic acidIBA 10/2021 - 03/2014
4	Durapatite (Hydroxylapatite)IBA 01/2016 - 07/2008
4	phosphonic acidIBA 12/2014 - 04/2008
3	Trastuzumab (Herceptin)FDA Link 04/2024 - 06/2022
3	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 04/2022 - 08/2004
3	AntigensIBA 10/2021 - 01/2016
3	DOTA(0)-Tyr(3)-Thr(8)- 90Y-octreotateIBA 03/2021 - 09/2020
3	lutetium Lu 177 dotatateIBA 01/2021 - 01/2016
3	Thyroglobulin FDA Link 01/2021 - 05/2015
3	1,4,7,10- tetraazacyclododecane- 1,4,7,10- tetrakis(methylenephosphonic acid) (DOTMP)IBA 01/2018 - 12/2013
2	Rituximab (Mabthera)FDA Link 09/2023 - 01/2017
2	LutetiumIBA 04/2022 - 07/2011
2	177Lu-PSMA-617IBA 04/2021 - 12/2019
2	Hemoglobins (Hemoglobin)IBA 01/2021 - 01/2016
2	EndotoxinsIBA 01/2020 - 11/2014
2	Tumor Biomarkers (Tumor Markers)IBA 10/2019 - 01/2016
2	Peptides (Polypeptides)IBA 01/2018 - 03/2013
2	Organophosphonates (Phosphonates)IBA 01/2018 - 05/2004
2	IntegrinsIBA 03/2017 - 03/2013
2	AntibodiesIBA 01/2017 - 07/2005
2	177Lu- 1,4,7,10- tetraazacyclododecane- 1,4,7,10- tetrakis(methylenephosphonic acid)IBA 12/2016 - 09/2008
2	MetalsIBA 01/2016 - 09/2008
2	MisonidazoleIBA 03/2015 - 03/2013
2	fluoromisonidazoleIBA 03/2015 - 08/2014
2	iminodiacetic acidIBA 08/2014 - 12/2006
2	Colchicine FDA LinkGeneric 08/2014 - 02/2006
2	NitroimidazolesIBA 08/2014 - 07/2005
2	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 08/2014 - 02/2006
2	Androgen Receptors (Androgen Receptor)IBA 10/2011 - 11/2006
2	Estrogen ReceptorsIBA 07/2011 - 07/2005
2	Ethiodized Oil (Ethiodol)FDA Link 10/2010 - 05/2009
2	Metronidazole (Metric)FDA LinkGeneric 07/2005 - 02/2003
1	AntiemeticsIBA 02/2024
1	Humanized Monoclonal AntibodiesIBA 09/2023
1	Lutetium-177IBA 09/2023
1	AutoantibodiesIBA 10/2022
1	Iodide Peroxidase (Deiodinase)IBA 10/2022
1	anti-thyroglobulinIBA 10/2022
1	pertuzumabIBA 06/2022
1	human ERBB2 proteinIBA 06/2022
1	Hormones (Hormone)IBA 10/2021
1	gallium 68 PSMA-11IBA 04/2021
1	Doxorubicin (Adriamycin)FDA LinkGeneric 12/2020
1	Fibroins (Fibroin)IBA 12/2020
1	AndrogensIBA 01/2020
1	Monoclonal AntibodiesIBA 12/2019
1	131I-rituximabIBA 12/2019
1	Membrane Glycoproteins (Membrane Glycoprotein)IBA 05/2019
1	N,N'- bis(2- hydroxy- 5- (ethylene- beta- carboxy)benzyl)ethylenediamine N,N'-diacetic acidIBA 05/2019
1	Androgen Antagonists (Antiandrogens)IBA 12/2018
1	jugloneIBA 09/2018
1	Ascorbic Acid (Vitamin C)FDA LinkGeneric 09/2018
1	CatalaseIBA 09/2018
1	CD13 Antigens (Alanine Aminopeptidase)IBA 01/2018
1	NGR peptideIBA 01/2018

Therapy/Procedure

30	Therapeutics 09/2023 - 08/2004
5	Palliative Care (Palliative Therapy) 01/2016 - 08/2002
4	Radioimmunotherapy 02/2024 - 01/2017
4	Precision Medicine 03/2017 - 01/2016
4	Radiotherapy 04/2011 - 09/2008
3	Drug Therapy (Chemotherapy) 01/2020 - 02/2006
2	Gamma Cameras (Gamma Camera) 02/2024 - 07/2010
2	Castration 04/2021 - 12/2018
1	Injections 01/2022
1	Orchiectomy (Orchidectomy) 10/2021
1	Secondary Prevention 01/2020